25 XP   0   0   10

PCI Biotech Holding ASA
Buy, Hold or Sell?

Let's analyse PCI Biotech Holding ASA together

PenkeI guess you are interested in PCI Biotech Holding ASA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of PCI Biotech Holding ASA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about PCI Biotech Holding ASA

I send you an email if I find something interesting about PCI Biotech Holding ASA.

Quick analysis of PCI Biotech Holding ASA (30 sec.)










What can you expect buying and holding a share of PCI Biotech Holding ASA? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr1.54
Expected worth in 1 year
kr3.45
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
kr1.92
Return On Investment
113.0%

For what price can you sell your share?

Current Price per Share
kr1.70
Expected price per share
kr1.524 - kr1.96
How sure are you?
50%

1. Valuation of PCI Biotech Holding ASA (5 min.)




Live pricePrice per Share (EOD)

kr1.70

Intrinsic Value Per Share

kr-16.41 - kr-0.64

Total Value Per Share

kr-14.87 - kr0.89

2. Growth of PCI Biotech Holding ASA (5 min.)




Is PCI Biotech Holding ASA growing?

Current yearPrevious yearGrowGrow %
How rich?$5.2m$10.3m-$5.1m-98.2%

How much money is PCI Biotech Holding ASA making?

Current yearPrevious yearGrowGrow %
Making money-$5m-$8m$3m60.4%
Net Profit Margin-1,159.9%-1,409.1%--

How much money comes from the company's main activities?

3. Financial Health of PCI Biotech Holding ASA (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#742 / 1010

Most Revenue
#557 / 1010

Most Profit
#427 / 1010

Most Efficient
#814 / 1010

What can you expect buying and holding a share of PCI Biotech Holding ASA? (5 min.)

Welcome investor! PCI Biotech Holding ASA's management wants to use your money to grow the business. In return you get a share of PCI Biotech Holding ASA.

What can you expect buying and holding a share of PCI Biotech Holding ASA?

First you should know what it really means to hold a share of PCI Biotech Holding ASA. And how you can make/lose money.

Speculation

The Price per Share of PCI Biotech Holding ASA is kr1.696. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of PCI Biotech Holding ASA.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in PCI Biotech Holding ASA, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr1.54. Based on the TTM, the Book Value Change Per Share is kr0.48 per quarter. Based on the YOY, the Book Value Change Per Share is kr-4.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of PCI Biotech Holding ASA.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps-0.13-7.9%-0.13-7.9%-0.07-4.4%-0.14-8.1%-0.11-6.5%
Usd Book Value Change Per Share0.042.6%0.042.6%-0.37-21.5%0.010.4%0.00-0.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.042.6%0.042.6%-0.37-21.5%0.010.4%0.00-0.2%
Usd Price Per Share0.19-0.19-1.27-2.67-2.21-
Price to Earnings Ratio-1.39--1.39--16.91--18.75--19.58-
Price-to-Total Gains Ratio4.28-4.28--3.47--8.98--4.93-
Price to Book Ratio1.33-1.33-13.14-6.86-19.02-
Price-to-Total Gains Ratio4.28-4.28--3.47--8.98--4.93-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.154336
Number of shares6479
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.040.01
Usd Total Gains Per Share0.040.01
Gains per Quarter (6479 shares)282.5349.16
Gains per Year (6479 shares)1,130.12196.63
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10113011200197187
20226022500393384
30339033800590581
40452045100787778
50565156400983975
6067816770011801172
7079117900013761369
8090419030015731566
901017110160017701763
1001130111290019661960

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.015.00.00.0%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%2.03.00.040.0%4.06.00.040.0%6.09.00.040.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.015.00.0%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%2.03.00.040.0%4.06.00.040.0%6.09.00.040.0%

Fundamentals of PCI Biotech Holding ASA

About PCI Biotech Holding ASA

PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in pre-clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Olix Pharmaceuticals, Aposense, IMV Immunovaccine, MDimune, eTheRNA, and Immunicum. PCI Biotech Holding ASA was incorporated in 2007 and is based in Oslo, Norway.

Fundamental data was last updated by Penke on 2024-04-24 10:40:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of PCI Biotech Holding ASA.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit PCI Biotech Holding ASA earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare PCI Biotech Holding ASA to the Biotechnology industry mean.
  • A Net Profit Margin of -1,159.9% means that kr-11.60 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of PCI Biotech Holding ASA:

  • The MRQ is -1,159.9%. The company is making a huge loss. -2
  • The TTM is -1,159.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,159.9%TTM-1,159.9%0.0%
TTM-1,159.9%YOY-1,409.1%+249.2%
TTM-1,159.9%5Y-971.8%-188.1%
5Y-971.8%10Y-679.4%-292.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,159.9%-200.1%-959.8%
TTM-1,159.9%-216.8%-943.1%
YOY-1,409.1%-288.3%-1,120.8%
5Y-971.8%-449.1%-522.7%
10Y-679.4%-605.5%-73.9%
1.1.2. Return on Assets

Shows how efficient PCI Biotech Holding ASA is using its assets to generate profit.

  • Above 5% is considered healthy but always compare PCI Biotech Holding ASA to the Biotechnology industry mean.
  • -86.8% Return on Assets means that PCI Biotech Holding ASA generated kr-0.87 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of PCI Biotech Holding ASA:

  • The MRQ is -86.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -86.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-86.8%TTM-86.8%0.0%
TTM-86.8%YOY-65.0%-21.8%
TTM-86.8%5Y-45.5%-41.3%
5Y-45.5%10Y-72.9%+27.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-86.8%-13.3%-73.5%
TTM-86.8%-12.8%-74.0%
YOY-65.0%-11.7%-53.3%
5Y-45.5%-13.9%-31.6%
10Y-72.9%-15.7%-57.2%
1.1.3. Return on Equity

Shows how efficient PCI Biotech Holding ASA is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare PCI Biotech Holding ASA to the Biotechnology industry mean.
  • -96.0% Return on Equity means PCI Biotech Holding ASA generated kr-0.96 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of PCI Biotech Holding ASA:

  • The MRQ is -96.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -96.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-96.0%TTM-96.0%0.0%
TTM-96.0%YOY-77.7%-18.3%
TTM-96.0%5Y-51.4%-44.6%
5Y-51.4%10Y-113.4%+62.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-96.0%-16.9%-79.1%
TTM-96.0%-16.1%-79.9%
YOY-77.7%-15.1%-62.6%
5Y-51.4%-19.3%-32.1%
10Y-113.4%-20.2%-93.2%

1.2. Operating Efficiency of PCI Biotech Holding ASA.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient PCI Biotech Holding ASA is operating .

  • Measures how much profit PCI Biotech Holding ASA makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare PCI Biotech Holding ASA to the Biotechnology industry mean.
  • An Operating Margin of -1,066.8% means the company generated kr-10.67  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of PCI Biotech Holding ASA:

  • The MRQ is -1,066.8%. The company is operating very inefficient. -2
  • The TTM is -1,066.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,066.8%TTM-1,066.8%0.0%
TTM-1,066.8%YOY-1,407.7%+340.8%
TTM-1,066.8%5Y-950.5%-116.3%
5Y-950.5%10Y-668.7%-281.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,066.8%-296.2%-770.6%
TTM-1,066.8%-232.5%-834.3%
YOY-1,407.7%-298.2%-1,109.5%
5Y-950.5%-492.1%-458.4%
10Y-668.7%-632.4%-36.3%
1.2.2. Operating Ratio

Measures how efficient PCI Biotech Holding ASA is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 11.88 means that the operating costs are kr11.88 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of PCI Biotech Holding ASA:

  • The MRQ is 11.884. The company is inefficient in keeping operating costs low. -1
  • The TTM is 11.884. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ11.884TTM11.8840.000
TTM11.884YOY13.714-1.831
TTM11.8845Y10.173+1.711
5Y10.17310Y7.076+3.097
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.8843.231+8.653
TTM11.8843.310+8.574
YOY13.7143.890+9.824
5Y10.1735.739+4.434
10Y7.0767.876-0.800

1.3. Liquidity of PCI Biotech Holding ASA.

1.3. Liquidity
1.3.1. Current Ratio

Measures if PCI Biotech Holding ASA is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 10.91 means the company has kr10.91 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of PCI Biotech Holding ASA:

  • The MRQ is 10.911. The company is very able to pay all its short-term debts. +2
  • The TTM is 10.911. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ10.911TTM10.9110.000
TTM10.911YOY6.137+4.774
TTM10.9115Y11.877-0.967
5Y11.87710Y7.797+4.080
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.9113.890+7.021
TTM10.9114.173+6.738
YOY6.1375.344+0.793
5Y11.8776.126+5.751
10Y7.7976.448+1.349
1.3.2. Quick Ratio

Measures if PCI Biotech Holding ASA is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare PCI Biotech Holding ASA to the Biotechnology industry mean.
  • A Quick Ratio of 10.91 means the company can pay off kr10.91 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of PCI Biotech Holding ASA:

  • The MRQ is 10.911. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 10.911. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ10.911TTM10.9110.000
TTM10.911YOY5.753+5.158
TTM10.9115Y11.637-0.726
5Y11.63710Y7.637+4.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.9113.514+7.397
TTM10.9113.998+6.913
YOY5.7535.380+0.373
5Y11.6376.105+5.532
10Y7.6376.404+1.233

1.4. Solvency of PCI Biotech Holding ASA.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of PCI Biotech Holding ASA assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare PCI Biotech Holding ASA to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.10 means that PCI Biotech Holding ASA assets are financed with 9.6% credit (debt) and the remaining percentage (100% - 9.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of PCI Biotech Holding ASA:

  • The MRQ is 0.096. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.096. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.096TTM0.0960.000
TTM0.096YOY0.163-0.067
TTM0.0965Y0.100-0.004
5Y0.10010Y0.214-0.115
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0960.339-0.243
TTM0.0960.336-0.240
YOY0.1630.271-0.108
5Y0.1000.366-0.266
10Y0.2140.389-0.175
1.4.2. Debt to Equity Ratio

Measures if PCI Biotech Holding ASA is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare PCI Biotech Holding ASA to the Biotechnology industry mean.
  • A Debt to Equity ratio of 10.6% means that company has kr0.11 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of PCI Biotech Holding ASA:

  • The MRQ is 0.106. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.106. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.106TTM0.1060.000
TTM0.106YOY0.195-0.089
TTM0.1065Y0.113-0.007
5Y0.11310Y0.340-0.227
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1060.388-0.282
TTM0.1060.402-0.296
YOY0.1950.335-0.140
5Y0.1130.426-0.313
10Y0.3400.461-0.121

2. Market Valuation of PCI Biotech Holding ASA

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings PCI Biotech Holding ASA generates.

  • Above 15 is considered overpriced but always compare PCI Biotech Holding ASA to the Biotechnology industry mean.
  • A PE ratio of -1.39 means the investor is paying kr-1.39 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of PCI Biotech Holding ASA:

  • The EOD is -1.149. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.389. Based on the earnings, the company is expensive. -2
  • The TTM is -1.389. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.149MRQ-1.389+0.240
MRQ-1.389TTM-1.3890.000
TTM-1.389YOY-16.915+15.526
TTM-1.3895Y-18.746+17.357
5Y-18.74610Y-19.577+0.831
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.149-2.264+1.115
MRQ-1.389-2.629+1.240
TTM-1.389-2.680+1.291
YOY-16.915-4.145-12.770
5Y-18.746-6.257-12.489
10Y-19.577-6.254-13.323
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of PCI Biotech Holding ASA:

  • The EOD is -1.072. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.296. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.296. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.072MRQ-1.296+0.224
MRQ-1.296TTM-1.2960.000
TTM-1.296YOY-21.888+20.592
TTM-1.2965Y-20.617+19.321
5Y-20.61710Y-21.868+1.251
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.072-2.973+1.901
MRQ-1.296-3.333+2.037
TTM-1.296-3.553+2.257
YOY-21.888-5.605-16.283
5Y-20.617-8.376-12.241
10Y-21.868-8.865-13.003
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of PCI Biotech Holding ASA is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.33 means the investor is paying kr1.33 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of PCI Biotech Holding ASA:

  • The EOD is 1.103. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.333. Based on the equity, the company is underpriced. +1
  • The TTM is 1.333. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.103MRQ1.333-0.230
MRQ1.333TTM1.3330.000
TTM1.333YOY13.139-11.806
TTM1.3335Y6.856-5.523
5Y6.85610Y19.016-12.160
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.1031.896-0.793
MRQ1.3332.115-0.782
TTM1.3332.093-0.760
YOY13.1392.884+10.255
5Y6.8563.542+3.314
10Y19.0163.916+15.100
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of PCI Biotech Holding ASA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.4790.4790%-4.011+937%0.083+475%-0.033+107%
Book Value Per Share--1.5381.5380%1.059+45%4.698-67%2.756-44%
Current Ratio--10.91110.9110%6.137+78%11.877-8%7.797+40%
Debt To Asset Ratio--0.0960.0960%0.163-41%0.100-4%0.214-55%
Debt To Equity Ratio--0.1060.1060%0.195-46%0.113-6%0.340-69%
Dividend Per Share----0%-0%-0%-0%
Eps---1.476-1.4760%-0.822-44%-1.501+2%-1.207-18%
Free Cash Flow Per Share---1.582-1.5820%-0.635-60%-1.465-7%-1.159-27%
Free Cash Flow To Equity Per Share---1.600-1.6000%-0.642-60%0.293-646%0.429-473%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.645--------
Intrinsic Value_10Y_min---16.409--------
Intrinsic Value_1Y_max---0.925--------
Intrinsic Value_1Y_min---1.525--------
Intrinsic Value_3Y_max---2.125--------
Intrinsic Value_3Y_min---4.714--------
Intrinsic Value_5Y_max---2.533--------
Intrinsic Value_5Y_min---8.020--------
Market Cap63305574.400-21%76519120.00076519120.0000%1495130260.000-95%1300870952.000-94%1009141806.736-92%
Net Profit Margin---11.599-11.5990%-14.091+21%-9.718-16%-6.794-41%
Operating Margin---10.668-10.6680%-14.077+32%-9.505-11%-6.687-37%
Operating Ratio--11.88411.8840%13.714-13%10.173+17%7.076+68%
Pb Ratio1.103-21%1.3331.3330%13.139-90%6.856-81%19.016-93%
Pe Ratio-1.149+17%-1.389-1.3890%-16.915+1118%-18.746+1250%-19.577+1310%
Price Per Share1.696-21%2.0502.0500%13.910-85%29.372-93%24.296-92%
Price To Free Cash Flow Ratio-1.072+17%-1.296-1.2960%-21.888+1589%-20.617+1491%-21.868+1587%
Price To Total Gains Ratio3.539-21%4.2784.2780%-3.468+181%-8.984+310%-4.934+215%
Quick Ratio--10.91110.9110%5.753+90%11.637-6%7.637+43%
Return On Assets---0.868-0.8680%-0.650-25%-0.455-48%-0.729-16%
Return On Equity---0.960-0.9600%-0.777-19%-0.514-46%-1.134+18%
Total Gains Per Share--0.4790.4790%-4.011+937%0.083+475%-0.033+107%
Usd Book Value--5223673.0005223673.0000%10355072.000-50%17385022.200-70%10073181.300-48%
Usd Book Value Change Per Share--0.0440.0440%-0.365+937%0.008+475%-0.003+107%
Usd Book Value Per Share--0.1400.1400%0.096+45%0.428-67%0.251-44%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.134-0.1340%-0.075-44%-0.137+2%-0.110-18%
Usd Free Cash Flow---5372822.000-5372822.0000%-6215937.000+16%-5811078.000+8%-4356270.100-19%
Usd Free Cash Flow Per Share---0.144-0.1440%-0.058-60%-0.133-7%-0.106-27%
Usd Free Cash Flow To Equity Per Share---0.146-0.1460%-0.058-60%0.027-646%0.039-473%
Usd Market Cap5760807.270-21%6963239.9206963239.9200%136056853.660-95%118379256.632-94%91831904.413-92%
Usd Price Per Share0.154-21%0.1870.1870%1.266-85%2.673-93%2.211-92%
Usd Profit---5013645.000-5013645.0000%-8043581.000+60%-6174368.200+23%-4637778.600-7%
Usd Revenue--432250.000432250.0000%570843.000-24%679733.600-36%750913.800-42%
Usd Total Gains Per Share--0.0440.0440%-0.365+937%0.008+475%-0.003+107%
 EOD+2 -6MRQTTM+0 -0YOY+18 -155Y+13 -2010Y+12 -21

3.2. Fundamental Score

Let's check the fundamental score of PCI Biotech Holding ASA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.149
Price to Book Ratio (EOD)Between0-11.103
Net Profit Margin (MRQ)Greater than0-11.599
Operating Margin (MRQ)Greater than0-10.668
Quick Ratio (MRQ)Greater than110.911
Current Ratio (MRQ)Greater than110.911
Debt to Asset Ratio (MRQ)Less than10.096
Debt to Equity Ratio (MRQ)Less than10.106
Return on Equity (MRQ)Greater than0.15-0.960
Return on Assets (MRQ)Greater than0.05-0.868
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of PCI Biotech Holding ASA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.563
Ma 20Greater thanMa 501.724
Ma 50Greater thanMa 1001.761
Ma 100Greater thanMa 2001.953
OpenGreater thanClose1.700
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Other Stockholders Equity  449,7681,834451,6022,343453,945-3,482450,463-505,039-54,576



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in NOK. All numbers in thousands.

Summary
Total Assets63,482
Total Liabilities6,079
Total Stockholder Equity57,403
 As reported
Total Liabilities 6,079
Total Stockholder Equity+ 57,403
Total Assets = 63,482

Assets

Total Assets63,482
Total Current Assets62,758
Long-term Assets723
Total Current Assets
Cash And Cash Equivalents 55,967
Net Receivables 6,162
Total Current Assets  (as reported)62,758
Total Current Assets  (calculated)62,129
+/- 629
Long-term Assets
Property Plant Equipment 721
Long-term Assets Other 2
Long-term Assets  (as reported)723
Long-term Assets  (calculated)723
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities5,752
Long-term Liabilities327
Total Stockholder Equity57,403
Total Current Liabilities
Accounts payable 495
Other Current Liabilities 4,814
Total Current Liabilities  (as reported)5,752
Total Current Liabilities  (calculated)5,309
+/- 443
Long-term Liabilities
Long term Debt Total 327
Long-term Liabilities  (as reported)327
Long-term Liabilities  (calculated)327
+/-0
Total Stockholder Equity
Common Stock111,979
Other Stockholders Equity -54,576
Total Stockholder Equity (as reported)57,403
Total Stockholder Equity (calculated)57,403
+/-0
Other
Capital Stock111,979
Cash And Equivalents56,596
Cash and Short Term Investments 56,596
Common Stock Shares Outstanding 37,326
Liabilities and Stockholders Equity 63,482
Net Invested Capital 57,403
Net Tangible Assets 57,403
Net Working Capital 57,006
Property Plant and Equipment Gross 13,152



Balance Sheet

Currency in NOK. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
> Total Assets 
1,001
54,576
41,528
114,541
100,165
78,201
52,736
20,382
56,399
22,398
58,436
357,056
282,032
209,123
135,978
63,482
63,482135,978209,123282,032357,05658,43622,39856,39920,38252,73678,201100,165114,54141,52854,5761,001
   > Total Current Assets 
0
54,380
41,348
114,463
100,148
78,201
52,718
20,368
56,389
22,393
58,414
357,039
275,749
201,129
128,318
62,758
62,758128,318201,129275,749357,03958,41422,39356,38920,36852,71878,201100,148114,46341,34854,3800
       Cash And Cash Equivalents 
1,001
50,142
35,823
110,814
95,115
72,620
46,106
15,182
48,688
13,433
50,197
348,628
259,976
187,168
115,180
55,967
55,967115,180187,168259,976348,62850,19713,43348,68815,18246,10672,62095,115110,81435,82350,1421,001
       Short-term Investments 
0
48,446
33,600
104,877
351
463
489
0
0
0
0
0
0
0
0
0
000000000489463351104,87733,60048,4460
       Net Receivables 
0
4,238
5,525
3,649
5,033
5,118
5,310
4,505
6,946
7,810
7,170
7,396
7,013
5,986
5,104
6,162
6,1625,1045,9867,0137,3967,1707,8106,9464,5055,3105,1185,0333,6495,5254,2380
       Other Current Assets 
0
4,238
5,525
3,649
5,033
5,581
6,612
5,186
7,701
8,960
8,217
8,411
15,773
13,961
13,138
0
013,13813,96115,7738,4118,2178,9607,7015,1866,6125,5815,0333,6495,5254,2380
   > Long-term Assets 
0
196
180
78
17
0
18
14
10
5
22
17
6,283
7,994
7,660
723
7237,6607,9946,28317225101418017781801960
       Property Plant Equipment 
0
119
153
78
17
0
18
14
10
5
22
17
6,283
7,994
7,660
721
7217,6607,9946,28317225101418017781531190
       Intangible Assets 
0
76
27
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000027760
       Other Assets 
0
1
0
0
0
0
0
0
0
0
0
0
0
1
0
1
1010000000000010
> Total Liabilities 
0
5,275
6,452
9,118
7,632
8,495
9,340
11,268
12,115
9,312
16,594
17,102
27,204
19,879
22,186
6,079
6,07922,18619,87927,20417,10216,5949,31212,11511,2689,3408,4957,6329,1186,4525,2750
   > Total Current Liabilities 
0
5,275
6,452
6,606
5,827
7,669
9,222
11,269
12,115
9,312
14,585
16,995
24,628
19,847
20,909
5,752
5,75220,90919,84724,62816,99514,5859,31212,11511,2699,2227,6695,8276,6066,4525,2750
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
657
673
629
0
0629673657000000000000
       Accounts payable 
0
2,728
2,557
2,047
2,168
1,984
4,061
2,586
3,371
2,080
1,497
1,889
8,601
5,191
3,745
495
4953,7455,1918,6011,8891,4972,0803,3712,5864,0611,9842,1682,0472,5572,7280
       Other Current Liabilities 
0
2,547
3,895
4,559
3,659
5,685
5,161
8,683
8,744
7,232
13,088
15,106
15,370
13,983
16,535
4,814
4,81416,53513,98315,37015,10613,0887,2328,7448,6835,1615,6853,6594,5593,8952,5470
   > Long-term Liabilities 
0
0
0
2,512
1,805
826
118
-1
0
0
2,009
107
2,576
32
1,277
327
3271,277322,5761072,00900-11188261,8052,512000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
539
0
1,277
327
3271,2770539000000000000
       Other Liabilities 
0
0
0
2,512
1,805
826
118
-1
0
0
2,009
107
2,037
32
0
0
00322,0371072,00900-11188261,8052,512000
> Total Stockholder Equity
1,000
49,301
35,076
105,423
92,533
69,706
43,396
9,115
44,285
13,086
41,843
339,954
254,829
189,244
113,792
57,403
57,403113,792189,244254,829339,95441,84313,08644,2859,11543,39669,70692,533105,42335,07649,3011,000
   Common Stock
1,000
16,249
16,249
22,999
22,999
22,999
23,179
23,179
44,701
44,701
74,961
111,494
111,797
111,979
111,979
111,979
111,979111,979111,979111,797111,49474,96144,70144,70123,17923,17922,99922,99922,99916,24916,2491,000
   Retained Earnings Total Equity0000000000000000
   Accumulated Other Comprehensive Income 00-3,481-1,273-320-315-309-304-300-296-292-275-214-139-660
   Capital Surplus 
0
0
0
0
0
0
0
0
0
120,678
157,148
449,448
450,329
450,464
562,443
0
0562,443450,464450,329449,448157,148120,678000000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
0
88,517
90,141
167,752
168,673
171,121
77,028
77,032
120,982
120,987
157,463
449,768
451,602
453,945
450,463
-54,576
-54,576450,463453,945451,602449,768157,463120,987120,98277,03277,028171,121168,673167,75290,14188,5170



Balance Sheet

Currency in NOK. All numbers in thousands.




Cash Flow

Currency in NOK. All numbers in thousands.




Income Statement

Currency in NOK. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue4,750
Cost of Revenue-0
Gross Profit04,750
 
Operating Income (+$)
Gross Profit0
Operating Expense-56,447
Operating Income-56,447-56,447
 
Operating Expense (+$)
Research Development44,756
Selling General Administrative16,441
Selling And Marketing Expenses0
Operating Expense56,44761,197
 
Net Interest Income (+$)
Interest Income1,110
Interest Expense-127
Other Finance Cost-369
Net Interest Income1,352
 
Pretax Income (+$)
Operating Income-56,447
Net Interest Income1,352
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-55,095-56,447
EBIT - interestExpense = -50,802
-55,095
-54,968
Interest Expense127
Earnings Before Interest and Taxes (EBIT)-50,675-54,968
Earnings Before Interest and Taxes (EBITDA)-48,562
 
After tax Income (+$)
Income Before Tax-55,095
Tax Provision-0
Net Income From Continuing Ops-55,095-55,095
Net Income-55,095
Net Income Applicable To Common Shares-55,095
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-1,352
 

Technical Analysis of PCI Biotech Holding ASA
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of PCI Biotech Holding ASA. The general trend of PCI Biotech Holding ASA is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine PCI Biotech Holding ASA's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of PCI Biotech Holding ASA.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.82 < 1.9 < 1.96.

The bearish price targets are: 1.57 > 1.57 > 1.524.

Tweet this
PCI Biotech Holding ASA Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of PCI Biotech Holding ASA. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

PCI Biotech Holding ASA Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of PCI Biotech Holding ASA. The current macd is -0.01260044.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the PCI Biotech Holding ASA price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for PCI Biotech Holding ASA. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the PCI Biotech Holding ASA price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
PCI Biotech Holding ASA Daily Moving Average Convergence/Divergence (MACD) ChartPCI Biotech Holding ASA Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of PCI Biotech Holding ASA. The current adx is 16.37.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell PCI Biotech Holding ASA shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
PCI Biotech Holding ASA Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of PCI Biotech Holding ASA. The current sar is 1.97048.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
PCI Biotech Holding ASA Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of PCI Biotech Holding ASA. The current rsi is 46.56. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
PCI Biotech Holding ASA Daily Relative Strength Index (RSI) ChartPCI Biotech Holding ASA Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of PCI Biotech Holding ASA. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the PCI Biotech Holding ASA price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
PCI Biotech Holding ASA Daily Stochastic Oscillator ChartPCI Biotech Holding ASA Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of PCI Biotech Holding ASA. The current cci is -68.02394251.

PCI Biotech Holding ASA Daily Commodity Channel Index (CCI) ChartPCI Biotech Holding ASA Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of PCI Biotech Holding ASA. The current cmo is -8.46691327.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
PCI Biotech Holding ASA Daily Chande Momentum Oscillator (CMO) ChartPCI Biotech Holding ASA Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of PCI Biotech Holding ASA. The current willr is -72.57142857.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that PCI Biotech Holding ASA is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
PCI Biotech Holding ASA Daily Williams %R ChartPCI Biotech Holding ASA Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of PCI Biotech Holding ASA.

PCI Biotech Holding ASA Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of PCI Biotech Holding ASA. The current atr is 0.14384785.

PCI Biotech Holding ASA Daily Average True Range (ATR) ChartPCI Biotech Holding ASA Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of PCI Biotech Holding ASA. The current obv is 704,948.

PCI Biotech Holding ASA Daily On-Balance Volume (OBV) ChartPCI Biotech Holding ASA Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of PCI Biotech Holding ASA. The current mfi is 49.45.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
PCI Biotech Holding ASA Daily Money Flow Index (MFI) ChartPCI Biotech Holding ASA Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for PCI Biotech Holding ASA.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-12BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-09MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-12MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

PCI Biotech Holding ASA Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of PCI Biotech Holding ASA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.563
Ma 20Greater thanMa 501.724
Ma 50Greater thanMa 1001.761
Ma 100Greater thanMa 2001.953
OpenGreater thanClose1.700
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of PCI Biotech Holding ASA with someone you think should read this too:
  • Are you bullish or bearish on PCI Biotech Holding ASA? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about PCI Biotech Holding ASA? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about PCI Biotech Holding ASA

I send you an email if I find something interesting about PCI Biotech Holding ASA.


Comments

How you think about this?

Leave a comment

Stay informed about PCI Biotech Holding ASA.

Receive notifications about PCI Biotech Holding ASA in your mailbox!